Scarica l'app Stockscreener
2.85
1.79%
0.05
Dopo l'orario di chiusura:
3.00
0.15
+5.26%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$2.80
Aprire:
$2.84
Volume 24 ore:
453.69K
Relative Volume:
0.61
Capitalizzazione di mercato:
$208.44M
Reddito:
$405.47M
Utile/perdita netta:
$53.66M
Rapporto P/E:
3.9583
EPS:
0.72
Flusso di cassa netto:
$131.28M
1 W Prestazione:
-0.18%
1M Prestazione:
-8.06%
6M Prestazione:
-26.74%
1 anno Prestazione:
-31.49%
Intervallo 1D:
$2.83
$2.9599
Intervallo di 1 settimana:
$2.66
$2.9599
Portata 52W:
$2.36
$4.61
Orasure Technologies Inc Stock (OSUR) Company Profile
Nome
Orasure Technologies Inc
Settore
Industria
Telefono
(503) 641-6115
Indirizzo
220 E FIRST ST, BETHLEHEM, PA
Confronta OSUR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
OSUR
Orasure Technologies Inc
|
2.85 | 204.05M | 405.47M | 53.66M | 131.28M | 0.72 |
|
ISRG
Intuitive Surgical Inc
|
482.34 | 169.15B | 9.15B | 2.61B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
195.96 | 55.18B | 21.39B | 1.59B | 2.55B | 5.56 |
|
RMD
Resmed Inc
|
288.28 | 41.63B | 5.15B | 1.40B | 1.65B | 9.51 |
|
ALC
Alcon Inc
|
86.48 | 41.88B | 9.93B | 1.12B | 1.58B | 2.25 |
|
WST
West Pharmaceutical Services Inc
|
246.22 | 17.28B | 2.90B | 467.20M | 306.90M | 6.37 |
Orasure Technologies Inc Stock (OSUR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-01-03 | Ripresa | Evercore ISI | In-line |
| 2021-09-22 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2020-08-21 | Iniziato | Evercore ISI | Outperform |
| 2020-08-10 | Iniziato | Citigroup | Buy |
| 2020-08-10 | Iniziato | JP Morgan | Neutral |
| 2020-08-07 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2020-06-25 | Iniziato | Lake Street | Buy |
| 2020-04-21 | Ripresa | Stephens | Equal-Weight |
| 2018-10-23 | Ripresa | Raymond James | Mkt Perform |
| 2018-07-16 | Downgrade | Stephens | Overweight → Equal-Weight |
| 2017-11-02 | Downgrade | Jefferies | Buy → Hold |
| 2017-02-09 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2016-06-13 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2015-11-05 | Reiterato | Mizuho | Buy |
| 2015-05-07 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| 2015-01-23 | Reiterato | Mizuho | Buy |
| 2014-06-12 | Reiterato | Canaccord Genuity | Buy |
| 2014-06-11 | Reiterato | Mizuho | Buy |
| 2012-12-21 | Iniziato | Mizuho | Buy |
| 2012-08-08 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
| 2012-07-05 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| 2012-03-27 | Iniziato | JMP Securities | Mkt Outperform |
Mostra tutto
Orasure Technologies Inc Borsa (OSUR) Ultime notizie
David Nierenberg's Q2 Moves: Concentrated Portfolio Sees Lyft and OraSure Additions, Cantaloupe Exit - AInvest
OraSure Technologies Inc. Recovery Hinges on Volume BreakoutLow Capital High Return Stock Plans Reviewed - 선데이타임즈
David Nierenberg Exits Cantaloupe Inc, Portfolio Down 10.6% - AInvest
OraSure Technologies Inc. stock prediction for this weekAI-Based Stock Behavior Forecast Engine - Newser
Is this a good reentry point in OraSure Technologies Inc.Free Value Investing Picks With Stability - Newser
Visualizing OraSure Technologies Inc. stock with heatmapsFree Pattern Breakout Entry Stock Forecast - Newser
Risk adjusted return profile for OraSure Technologies Inc. analyzedSwing Trade Picks with High Potential - Newser
OraSure Technologies, Inc. (NASDAQ:OSUR) Analysts Are Pretty Bullish On The Stock After Recent Results - simplywall.st
What momentum shifts mean for OraSure Technologies Inc.Equity Performance Forecast Based on AI Models - Newser
Why OraSure Technologies Inc. stock attracts strong analyst attentionFree Weekly Setup With 3x Return Potential - Newser
OraSure Technologies, Inc. (NASDAQ:OSUR) Q2 2025 Earnings Call Transcript - Insider Monkey
OraSure (OSUR) Q2 Revenue Falls 43% - AOL.com
OraSure Technologies Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
Orasure Technologies 2025 Q2 Earnings Deepened Losses Amid Sharp Revenue Drop - AInvest
OraSure Q2 Earnings Call: Revenue Growth, Innovation Progress, and Challenges Ahead - AInvest
OraSure reports second quarter earnings amid 'continued uncertainty' - WFMZ.com
OraSure Technologies Q2 2025 Earnings: Revenue Down 43%, EPS Misses Expectations - AInvest
OraSure Reports Q2 Earnings in Line with Expectations, Raises Novel Blood Collection Device for Proteomic Research - AInvest
OraSure Technologies Q2 Financial Results: $19.7 Million LossNews and Statistics - IndexBox
OraSure Technologies Inc (OSUR) Q2 2025 Earnings Call Highlights: Navigating Challenges with ... - Yahoo Finance
OraSure signals Q3 revenue outlook of $27M–$30M as it launches new proteomics product and completes manufacturing transition - MSN
OraSure Technologies Inc (OSUR) Q2 2025 Earnings Call Highlights: Navigating Challenges with ... By GuruFocus - Investing.com Canada
OraSure: Q2 Earnings Snapshot - Greenwich Time
OraSure Technologies Reports Q2 2025 Financial Results - TipRanks
OraSure's Strategic Transformation: A High-Conviction Play in the Evolving Diagnostics Sector - AInvest
OraSure's Q2 2025: Unpacking Key Contradictions in Margins, Demand, and Revenue Outlook - AInvest
OraSure Q3 Revenue Outlook Revised to $27M-$30M Amid New Proteomics Product Launch and Manufacturing Transition Completion. - AInvest
OraSure’s Covid Come-Down Triggers Revenue Drop, But Outlook Brightens - Finimize
Transcript : OraSure Technologies, Inc., Q2 2025 Earnings Call, Aug 05, 2025 - MarketScreener
Earnings call transcript: OraSure Q2 2025 results show mixed performance By Investing.com - Investing.com Canada
Earnings call transcript: OraSure Q2 2025 results show mixed performance - Investing.com India
OraSure Technologies (OSUR) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance
OraSure Technologies Q2 Earnings: -$19.69mln, -$0.26 EPS, $31.24mln Revenue - AInvest
OraSure Technologies Inc reports results for the quarter ended June 30Earnings Summary - TradingView
OraSure Q2 Revenue Down 43% Amidst Appointments and M&A Activity - AInvest
OraSure Q2 revenue falls 43% - MarketScreener
OraSure Technologies Reports 43% Revenue Decline in Q2 2025 - TipRanks
OraSure Announces Second Quarter 2025 Financial Results - GlobeNewswire
RENEW 8-K: Ninth SPAC Extension Adds $250k to Trust, Deadline Sep 5 2025 | OSUR SEC FilingForm 8-K - Stock Titan
CRISPR-Based Diagnostics Market Driven by Rapid Detection - openPR.com
OraSure Appoints Anne Messing as Chief Commercial Officer - The Manila Times
Wave Life Sciences Ltd. shares rise 6.03% premarket after OraSure Technologies appoints new Chief Commercial Officer. - AInvest
What analysts say about OraSure Technologies Inc. stockInvest smarter with actionable trading signals - Jammu Links News
How volatile is OraSure Technologies Inc. stock compared to the marketAchieve superior returns through strategic trading - Jammu Links News
What makes OraSure Technologies Inc. stock price move sharplyInvest confidently with real-time market updates - Jammu Links News
What institutional investors are buying OraSure Technologies Inc. stockFree Stock Market Query - Jammu Links News
Why OraSure Technologies Inc. is moving todayExpert-Backed High Yield Stock Watchlist - Newser
What is the risk reward ratio of investing in OraSure Technologies Inc. stockUnlock exclusive stock market forecasts - Jammu Links News
Orasure Technologies Inc Azioni (OSUR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.74%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):